Editorial: Tangled loyalties at top of stem cell institute
By Sacramento Bee,
Sacramento Bee
| 11. 25. 2007
Behind conflict-of-interest controversy is real problem: The chairman's leadership
Internal conflicts have hurt and hampered the oversight committee of California's $3 billion stem cell institute since voters created it in 2004 by passing Proposition 71.
As designed by Robert Klein, the author of that initiative, a majority of this 29-member oversight committee consists of administrators and scientists whose institutions have a stake in the taxpayer money the board hands out for stem cell research.
Although members of the "Independent Citizens Oversight Committee" are required to abstain from all decisions that could directly affect them or their institutions, at least one has now been caught using back channels in an attempt to influence a major grant.
//
//]]>
John Reed, a respected scientist and oversight board member who heads the Burnham Institute in La Jolla, became disappointed earlier this year when the institute's staff ruled that a Burnham-affiliated researcher was ineligible to receive a $638,000 grant. Institute reviewers and the oversight board (with Reed abstaining) had already approved the grant, but the institute's staff later determined the researcher was not a full-time Burnham employee.
In an Aug...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...